Deja Vu is a modern hybrid-indica strain whose exact origins and development history remain undocumented by breeders. While its lineage is often associated with Chem 91 Skunk VA, there is no verified breeder description to confirm the specific cross or the intent behind its creation. Consequently, the development timeline and the identity of those responsible for bringing this strain to market remain subjects of speculation within the industry, as no formal cultivation records have been publicly established.

The terpene profile for Deja Vu is led by pinene, followed by myrcene, caryophyllene, limonene, ocimene, beta-pinene, humulene, linalool, bisabolol, guaiol, and nerolidol. Its cannabinoid content features an estimated 29% THC with approximately 0% CBD, though these figures are based on averaged data rather than batch-specific testing. Given this complex terpenoid array, the strain likely offers a multi-layered aromatic profile that transitions through the sharper, woody notes of pinene into the earthy, spicy, and floral undertones provided by its secondary and tertiary compounds.

Cultivators working with the strain note a flowering period of 63 days, with plants demonstrating enough resilience to thrive in both indoor and outdoor environments. Successfully managed, the strain produces an estimated high yield for growers of moderate experience. Clinically, Deja Vu is reported to deliver effects that are both relaxed and focused, making it a functional option for users managing pain, stress, or sleep-related concerns. There are currently no notable offspring recorded for this variety.